USE OF ANTI-EPCAM ANTIBODIES IN CANCER THERAPY

MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES

Anti-CCR8 antibodies and uses thereof

INTEGRIN BETA7 ANTAGONISTS AND METHODS OF TREATING CROHN'S DISEASE

METHODS OF ADMINISTERING BETA7 INTEGRIN ANTAGONISTS

ANTI-ICOS ANTIBODIES

NOVEL ANTI-CD47 ANTIBODIES AND USES THEREOF

METHODS OF TREATMENT USING ILT7 BINDING PROTEINS

METHODS OF TREATING LICHEN PLANUS USING INTERLEUKIN (IL-17) ANTAGONISTS

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR

COMPOSITIONS AND METHODS OF TREATING THROMBOSIS

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Cancer Neoepitopes

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

Combination therapies using an anti-BCMA antibody drug conjugate (ADC) in combination with a gamma secretase inhibitor (GSI)

USE OF VDAS TO ENHANCE IMMUNOMODULATING THERAPIES AGAINST TUMORS

Drug for Treating Cancer, Combination Drug, Drug Composition, Immune Responsive Cell, Nucleic Acid Delivery Vehicle, and Product

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS

ANTI-PD-L1 ANTIBODY AND PHARMACEUTICAL USE THEREOF

TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF

Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof

RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF

ANTIBODIES BINDING TIGIT AND USES THEREOF

TREATMENT AND DIAGNOSIS OF MENTAL DISORDERS

High Concentration Bispecific Antibody Formulations

ANTIGEN-BINDING MOLECULE FOR PROMOTING ELIMINATION OF ANTIGENS

Methods of Treating Cancer with an Anti-CD39 Antibody

BINDING PROTEINS TO CUB DOMAIN-CONTAINING PROTEIN (CDCP1)

ANTI-EPHA10 ANTIBODIES AND METHODS OF USE THEREOF

HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

Agonists of TREM2

NOVEL ANTI-SEMA3A ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS INVOLVING CHIMERIC BINDING POLYPEPTIDES

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

USE OF IL-1BETA BINDING ANTIBODIES

ANTI-IL-27 ANTIBODIES AND USES THEREOF

ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE

Generation of a new site-specific monoclonal antibody for tau protein and its use as a tool in specific biomarkers for early detection of neurodegenerative diseases and pathologies

ANTIBODY AGAINST SUPER-REPRESSOR IkB AND USE THEREOF

Long-lasting GLP1 analogue drug for type-2 diabetes

ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT

Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format

HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

PEPTIDE VACCINE BASED ON A NEW UNIVERSAL INFLUENZA A HEMAGGLUTININ HEAD DOMAIN EPITOPE AND HUMAN MONOCLONAL ANTIBODIES BINDING THERETO

COMBINATION THERAPY

GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREATING HEMATOPOIETIC MALIGNANCIES

Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain

ALBUMIN-PD-1 PACLITAXEL NANOPARTICLE COMPLEX COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

SIALIDASE-CD20-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

ANTIBODIES FOR BINDING PLASMINOGEN

Antibodies that bind to C1S and uses thereof

ANTI-CD154 ANTIBODIES AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING PRION PROTEIN-SPECIFIC ANTIBODY

Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases

MODULATION OF IMMUNE RESPONSE USING BTLA AGONIST ANTIBODIES

ANTI-ICOS ANTIBODIES

METHODS FOR TREATMENT OF B CELL PROLIFERATIVE DISORDERS WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

METHODS FOR TREATING TYPE 1 DIABETES

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

TRANSGENE GENETIC TAGS AND METHODS OF USE

Anti-MS4A6A antibodies and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

METHODS OF TREATING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) USING IL-17RA ANTIBODY

ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES

ANTIBODY COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Splicing modulator antibody-drug conjugates and methods of use

RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE THEREOF

Anti-c-Met antibody drug conjugates

FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS

ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Method of producing an immunoligand/payload conjugate

CONJUGATED CHIMERIC PROTEINS

TREATING TISSUE FIBROSIS AND/OR INJURY AND/OR ORGAN FAILURE WITH INTERLEUKIN 24 OR INTERLEUKIN 20 ANTAGONIST

Methods of using OX40 ligand encoding polynucleotides

GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREATING SOLID TUMORS

Anti-FOLR1 Immunoconjugate Dosing Regimens

Methods for Identifying Cancer Patients for Combination Treatment

SIALIDASE-PD-L1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

INHIBITION OF THE VE-PTP PHOSPHATASE PROTECTS THE KIDNEY FROM ISCHEMIA-REPERFUSION INJURY

MATERIALS AND METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE

MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER

ANTIBODIES AGAINST THE POLIOVIRUS RECEPTOR (PVR) AND USES THEREOF

Anti-CD39 Antibody Compositions and Methods

Treatment and Prevention of Ischemic Diseases And/Or Ischemic Tissue Damages

ANTI-CD40 BINDING MOLECULES AND BI-SPECIFIC ANTIBODIES COMPRISING SUCH

SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD

Anti-CD123 antibodies and conjugates and derivatives thereof

A PHARMACEUTICAL COMPOSITION FOR TREATING HEMATOLOGICAL CANCER

METHODS FOR TREATING POST INFECTIOUS AUTOIMMUNE DIABETES

Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD32B and CD79b and Uses Thereof

DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS

ANTI-TREM-1 ANTIBODIES AND USES THEREOF

METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS

CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23

Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

Antigen Specific Binding Domains and Antibody Molecules

ANTI-BETA-AMYLOID ANTIBODY FOR TREATING ALZHEIMER'S DISEASE

Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof

SARS-COV-2 SPIKE PROTEIN ANTIBODIES

NANO ANTIBODY FOR NEUTRALIZING TOXICITY OF SARS-COV-2 AND PREPARATION METHOD AND APPLICATION THEREOF

FUSION POLYPEPTIDES BINDING ANTIBODY FC DOMAINS AND INTEGRIN AND METHODS OF USE

Therapeutic Biologic For Treatment Of Hepatocellular Carcinoma

NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

METHODS AND MATERIALS FOR TARGETED EXPANSION OF IMMUNE EFFECTOR CELLS

COMBINATION THERAPY OF CARBOPLATIN AND NAPI2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES

ANTI-TSLP ANTIBODY AND USES THEREOF

Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

Combination therapies for treating cancer

TARGETED DELIVERY OF TUMOR MATRIX MODIFYING ENZYMES

CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF

CD123 binding proteins and related compositions and methods

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

Methods of treatment using CCR8 antibodies

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof

MULTISPECIFIC BINDING MOIETIES COMPRISING NOVEL PD-1 BINDING DOMAINS

Heterodimeric Antibodies That Bind to CD38 and CD3

P116 antibodies

ANTI-TIGIT ANTIBODIES AND APPLICATION THEREOF

ANTI-LRRC25 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFLAMMATORY PHENOTYPES AND USES THEREOF

Arthritis treatment

METHODS OF TREATING AUTOIMMUNE DISEASES USING INTERLEUKIN-17 (IL-17) ANTAGONISTS

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23

Signature of TL1A (TNFSF15) signaling pathway

VEGF-BINDING MOLECULES

LTBP complex-specific inhibitors of TGFβ and uses thereof

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE

AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF

Polypeptides antagonizing Wnt signaling in tumor cells

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS

Antibodies Against Fentanyl and Fentanyl Analogs

Binding molecules for BCMA and CD3

Sequences of anti-ecto-5'-nucleotidase antibodies

INHIBITION OF ATF7IP AND SETDB1 FOR CANCER TREATMENT

Humanized complement 5A receptor 1 antibodies and methods of use thereof

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

CLEC9A BINDING AGENTS

CD47 antigen-binding molecules

Human anti-semaphorin 4D antibody

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

Anti-claudin 6 Antibody and Antibody-drug Conjugate

IL-5 antibody, antigen binding fragment thereof, and medical application therefor

Anti-Coronavirus Antibodies and Methods of Use

T-cell modulatory multimeric polypeptides and methods of use thereof

CYTOKINE PRODRUGS AND DUAL-PRODRUGS

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

Method of treating transitional cell carcinoma in a canine by administering lapatinib, wherein the carcinoma harbors a BRAF mutation

Methods for treating GI syndrome and graft versus host disease

Immune stimulating micelle composition

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

CAR NKTs Expressing Artificial Micro RNA-Embedded shRNA for Downregulation of MHC Class I & II Expression

Enhanced immune cells using dual shRNA and composition including the same

ADOPTIVE T-CELL THERAPY USING EMPD-SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR TREATING lgE-MEDIATED ALLERGIC DISEASES

PLAP-CD3 EPSILON BISPECIFIC ANTIBODIES

DOSING FOR ANTI-TRYPTASE ANTIBODIES

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING DIABETIC RETINOPATHY

MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT AGAINST CANINE CD20

ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

Anti-CXCR2 antibodies and uses thereof

Antibodies or antigen-binding fragments that bind to OX40

BISPECIFIC ANTIBODY AGAINST Alpha-SYN/IGF1R AND USE THEREOF

A NOVEL ANTI-PD-L1/ANTI-LAG-3 BISPECIFIC ANTIBODY AND USES THEREOF

USE OF FGFR INHIBITORS IN FGFR-GENETICALLY ALTERED CANCERS TO ENHANCE PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN SEQUENTIAL TREATMENT SETTINGS

Quantitative Spatial Profiling for LAG-3 Antagonist Therapy

ANTIGEN SPECIFIC CD19-TARGETED CAR-T CELLS

CONFORMATION-SPECIFIC ANTIBODIES THAT BIND NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS

COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF

ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF

METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS

ANTI-TUMOR DNA VACCINE WITH PD-1 AND LAG-3 PATHWAY BLOCKADE

GALECTIN-TARGETING IMMUNOTHERAPY

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

NOVEL TREATMENT

USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE

ANTI-GLYCAN ANTIBODIES AND USES THEREOF

DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION

CO-INHIBITION OF CD47/SIRPalpha BINDING AND NEDD8-ACTIVATING ENZYME E1 REGULATORY SUBUNIT FOR THE TREATMENT OF CANCER

UPAR ANTIBODIES AND FUSION PROTEINS WITH THE SAME

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

ANTIBODY TARGETING BCMA, BISPECIFIC ANTIBODY, AND USE THEREOF

TNFRSF25-MEDIATED TREATMENTS OF IMMUNE DISEASES AND DISORDERS

Chimeric antigen receptors targeting B-cell maturation antigen

DOSE

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

RECOMBINANT PROTEIN TARGETING PD-L1 AND VEGF

Activity Modulator

ANTIBODY AND BISPECIFIC ANTIBODY TARGETING LAG-3 AND USE THEREOF

ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN AND USE THEREOF

COMBINATION THERAPY WITH CGRP ANTAGONISTS

YKL-40-TARGETING HUMAN MONOCLONAL ANTIBODY

ANTI-ALPHA-SYNUCLEIN ANTIBODIES

MEDICINAL PREPARATION FOR TREATING FIBROSIS WITH ANTI BSP ANTIBODIES

THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMENTIA

CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

T-cell modulatory multimeric polypeptides and methods of use thereof

Dual cytokine fusion proteins comprising IL-10

PURIFIED ANTIBODY COMPOSITION

COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

Modified Cell Expressing Therapeutic Agent and Uses thereof

POLYPEPTIDE FORMULATIONS

METHOD FOR TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR

Method of treating solid cancers and/or metastases thereof, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereof

CD8-specific antibody constructs and compositions thereof

HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM

Stabilized Formulations Containing Anti-MUC16 x Anti-CD3 Bispecific Antibodies

RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-MEDIATED KIDNEY DISORDERS

USE OF ANTI-PCSK9 ANTIBODY IN METHOD FOR PREVENTING OR TREATING CHOLESTEROL-RELATED DISEASE

ANTI-Eva1 PROTEIN ANTIBODY

SENSITIZATION OF TUMORS TO THERAPIES THROUGH ENDOGLIN ANTAGONISM

A METHOD FOR PREVENTING HUMAN VIRUS ASSOCIATED DISORDERS IN PATIENTS

ANTI-B7-H3 ANTIBODY AND APPLICATION THEREOF

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

SUBCUTANEOUS ADMINISTRATION OF ANTIBODIES FOR THE TREATMENT OF DISEASE

BISPECIFIC ANTIBODY TARGETING PD-1 AND TIM-3

HUMAN-DERIVED ANTI-HUNTINGTIN (HTT) ANTIBODIES AND USES THEREOF

Complement C2 Binding Proteins and Uses Thereof

SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING THE SAME

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Methods and compositions for modulating CAR-T activity

Compounds and methods for use in detecting gabapentin

Methods for Predicting and Modulating Glycation of a Protein

MONOCLONAL ANTIBODY WHICH TARGETS TFPI

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

COMPOSITIONS AND METHODS TARGETING THE NUCLEOTIDE FREE STATE OF RAS TO BLOCK ONCOGENIC SIGNALING AND TRANSFORMATION

ANTI-TLR4 ANTIBODIES AND USES THEREOF

Bispecific Antibody, Preparation Method Therefor and Application Thereof

ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS

Anti-CD40 antibodies and uses thereof

Methods for the treatment of thyroid eye disease

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING SICKLE CELL NEPHROPATHY AND CHRONIC KIDNEY DISEASE ASSOCIATED WITH SICKLE CELL DISEASE

PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

ANTIBODIES

Anti-PD-1 antibodies and methods of treating cancer

ANTI-CANINE PD-1 ANTIBODY BINDING WITH CANINE PD-1

ANTIBODY CLEAVAGE SITE BINDING MOLECULE

Markers of acute myeloid leukemia stem cells

IMMUNOTHERAPY COMPOUNDS AND METHODS

ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF

ANTAGONISTS ANTI-CD7 ANTIBODIES

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

ANTI-VEGF SINGLE-DOMAIN ANTIBODY AND USE THEREOF

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

ANTI-ALPHA-HEMOLYSIN ANTIBODY AND USE THEREOF

CD33 TARGETED IMMUNOTHERAPIES

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

Targeted modified TNF family members

RADIOLABELLED ANTIBODY FRAGMENTS FOR USE IN TREATING CANCER

NOVEL MOLECULAR TOOLS TO VISUALIZE AND TARGET THE CARDIAC CONDUCTION SYSTEM (CCS)

Pharmaceutical Formulations of Bi-Specific Diabodies and Use of the Same

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION

Gene-regulating compositions and methods for improved immunotherapy

PROTEASE SUBSTRATE, AND POLYPEPTIDE INCLUDING PROTEASE CLEAVAGE SEQUENCE

METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK

ANTI-HER2 AFFIBODY AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2

Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof

Trispecific antibody targeting CD79b, CD20, and CD3

NOVEL POLYPEPTIDE SELECTIVELY BINDING TO HUMAN PROGRAMMED CELL DEATH PROTEIN (PD-1) AND USE THEREOF

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF

ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR

Anti-Siglec-5 antibodies and methods of use thereof

BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF

BISPECIFIC BINDING AGENT THAT BINDS TO CD117/c-KIT AND CD3

Anti-TDP-43 Binding Molecules and Uses Thereof

ZIKA ANTIBODIES AND THEIR USE

COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS

USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIC PATIENTS

NEF-CONTAINING T CELLS AND METHODS OF PRODUCING THEREOF

QUINOLINE DERIVATIVE AND ANTIBODY SOFT TISSUE SARCOMA COMBINATION THERAPY

THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF SHOCK

VARIANT NUCLEIC ACID LIBRARIES FOR TIGIT

Heterodimeric antibodies that bind CD3 and GPC3

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

NOVEL ANTI-CLDN18.2 ANTIBODIES

GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE THEREOF

BCMA ANTIBODY